BioCentury's websites will be down for upgrades starting at 9 p.m. PDT on Monday, August 26. We expect the downtime to last no more than 6 hours, and we apologize for any inconvenience.

12:00 AM
May 08, 2006
 |  BioCentury  |  Finance

U.S. investment in Europe

U.S. investment in Europe

U.S. investment in Europe
European venture rounds in excess of $30 million in the past year. Selected firms that do not list a major office in Europe are in boldface. Temasek and NIF Ventures are based in Asia. Quintiles is headquartered in the U.S. (A) The series B round includes E8 million ($9.6 million) of convertible debt raised in 2005 that was converted to series B shares, E13 million ($15.5 million)...

Read the full 379 word article

User Sign in

Trial Subscription

Get a 4-week free trial subscription to BioCentury

Article Purchase

$150 USD
More Info >